Respiratory pathogen panels
Methodology
Nucleic Acid Amplification (NAA)
Test Description
This test is designed to simultaneous qualitative detection and identification of nucleic acids of Respiratory pathogens in nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections.
COVID-19 With Influenza A/B and Respiratory Syncytial Virus, NAA (Test code-105)
SARS-Cov-2
Influenza A virus Panel (H1 and H3)
Influenza A virus H1-2009
Influenza A virus H3
Influenza B virus
Respiratory Syncytial Virus
Respiratory Pathogen Profile, PCR (Test code 106)
VIRAL PATHOGENS
Adenovirus 1 & 2
Cytomegalovirus(CMV/HHV5)
Epstein-Barr virus (EBV/HHV4)
Human Parechovirus
Human Respiratory syncytical virus A & B
Human Bocavirus
Human Rhinoviruses 1
Human Coronavirus 229E
Human Rhinoviruses 2
Human Coronavirus HKUI
Human Coronavirus NL63
Human Coronavirus OC43
Human Enteroviruses Panel (All human viruses, except EV_D68)
Human Enterovirus_D68
Human herpesvirus 6(HHV6)
Human metapneumovirus
Human Parainfluenza virus 1
Human Parainfluenza virus 2
Human Parainfluenza virus 3
Human Parainfluenza virus 4
Influenza A virus Panel (H1 and H3)
Influenza A virus H1-2009
Influenza A virus H3
Influenza B virus
Measles Virus
Middle East respiratory syndrome (MERS)
Mumps virus
Severe Acute Respiratory Syndrome Coronavirus (SARS)
Varicella zoster virus (VZV/HHV3)
BACTERIAL PATHOGENS
Bordetella Panel (B.pertussis+B.bronchiseptica+B.parapertussis)
Bordetella holmesii
Bordetella pertussis
Chlamydophila pneumoniae
Coxiella burnetii
Haemophilus influenzae
Klebsiella pneumoniae
Legionella pneumoniae
Moraxella catarrhalis
Mycoplasma pneumoniae
Staphylococcus aureus
Streptococcus pyogenes
Streptococcus pneumoniae
FUNGAL PATHOGEN
Pneumocystis Jirovecii
Specimen Requirements
Specimen type: Anterior nasal swab; nasopharyngeal Swab, mid-turbinate swab
Volume: One swab in viral transport, 0.3 mL minimum
Container: Viral Transport System
Storage Instructions: Per the package insert: Swabs in viral transport media are stable for 30 days at -15°C or below. Swabs in viral transport media are also stable for 4 hours at room temperature and 3 days refrigerated (2º to 8º C).
Causes for Rejection: Improper collection; inadequate specimen; improper labeling; specimen leaked in transit; quantity not sufficient for analysis; name discrepancies; specimen exceeding storage requirements; specimen types other than nasopharyngeal swab in viral transport media
Limitations
This test has been validated according to the FDA guidelines, by CLIA # 45D2209248. Our laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C section 263a, to perform high complexity tests. The assay is validated internally by COLA guidance. Test performance can be affected because the clinical spectrum of infection caused by SARS-CoV-2 is not fully known.
Expected Turnaround Time
1 day. Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider.
CPT: 87636, 87486; 87581; 87633; 87798